# A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis

> **NCT02624310** · PHASE2 · WITHDRAWN · sponsor: **NYU Langone Health**

## Conditions studied

- HSAN Type IV

## Interventions

- **DRUG:** Droxidopa (L-DOPS)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02624310
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-01
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2016-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02624310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02624310, "A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02624310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*